ArticleFrontiers in oncology2024

The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy.

Yanyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.